{
  "query": "adverse months prednisone serious",
  "studies": {
    "protocolSection": [
      {
        "identificationModule": {
          "nctId": "NCT01940094",
          "briefTitle": "The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Granulomatosis With Polyangiitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 159,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00001379",
          "briefTitle": "Treatment and Natural History Study of Lymphomatoid Granulomatosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "1995-05-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-01-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Lymphomatoid Granulomatosis", "Granulomatosis, Lymphomatoid", "Non-Hodgkins Lymphoma", "Lymphoproliferative Disorder"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 94,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03312907",
          "briefTitle": "A Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) - BLISS-BELIEVE"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-03-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-07-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Systemic Lupus Erythematosus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 292,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02133924",
          "briefTitle": "Multicenter Study Of Natalizumab Plus Standard Steroid Treatment For High Risk Acute Graft-Versus-Host Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-11-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Graft Versus Host Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 76,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07252804",
          "briefTitle": "Immunogenicity and Safety of MenB Vaccine in Pediatric Patients With Autoimmune Rheumatic Diseases"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-01-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-12-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Autoimmune Rheumatologic Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 263,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "25 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05841758",
          "briefTitle": "Hydroxychloroquine as a Steroid-sparing Agent in Extrapulmonary Sarcoidosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-07-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-07-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Sarcoidosis, Pulmonary"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 140,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01193842",
          "briefTitle": "Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-10-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-05-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["AIDS-Related Plasmablastic Lymphoma", "AIDS-Related Primary Effusion Lymphoma", "Ann Arbor Stage I Diffuse Large B-Cell Lymphoma", "Ann Arbor Stage I Grade 3 Follicular Lymphoma", "Ann Arbor Stage II Diffuse Large B-Cell Lymphoma", "Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma", "Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma", "Ann Arbor Stage III Diffuse Large B-Cell Lymphoma", "Ann Arbor Stage III Grade 3 Follicular Lymphoma", "Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma", "Ann Arbor Stage IV Grade 3 Follicular Lymphoma", "HIV Infection", "Plasmablastic Lymphoma", "Primary Effusion Lymphoma", "Recurrent Diffuse Large B-Cell Lymphoma", "Recurrent Grade 3 Follicular Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 107,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00035555",
          "briefTitle": "Study Comparing the Safety and Efficacy of Belatacept With That of Cyclosporine in Patients With a Transplanted Kidney"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2001-03"
          },
          "completionDateStruct": {
            "date": "2012-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Graft Rejection", "Kidney Transplantation", "Renal Transplantation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 230,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04296578",
          "briefTitle": "Study Evaluating Sodium Selenite in Combination With Abiraterone in Castrate Resistant Prostate Cancer Progressing on Abiraterone"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-10",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2023-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Prostate Cancer", "Castrate Resistant Prostate Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02200146",
          "briefTitle": "Hydroxychloroquine as Steroid-Sparing Agent in Pulmonary Sarcoidosis (HySSAS)."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-03"
          },
          "completionDateStruct": {
            "date": "2013-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pulmonary Sarcoidosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 94,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06548919",
          "briefTitle": "Current Status of Treatment for Chinese Patients With ESR1-mutated HR+/HER2-advanced Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-08-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["ESR1 Gene Mutation", "Advanced Breast Cancer"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 450,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00114738",
          "briefTitle": "EPOCH-R Chemotherapy Plus Bortezomib to Treat Mantle Cell Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-06-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-08-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Lymphoma, Mantle Cell", "Mantle Cell Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 53,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02704429",
          "briefTitle": "A Study of PRN1008 in Adult Patients With Pemphigus Vulgaris"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-01-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-01-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pemphigus Vulgaris"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 42,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03018535",
          "briefTitle": "Rituximab Versus Steroids and Cyclophosphamide in the Treatment of Idiopathic Membranous Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-01"
          },
          "completionDateStruct": {
            "date": "2019-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Glomerulonephritis, Membranous"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 76,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07287397",
          "briefTitle": "Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12-18",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-10-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Amyotrophic Lateral Sclerosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07160205",
          "briefTitle": "Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Idiopathic Inflammatory Myositis (IIM)", "DERMATOMYOSITIS OR POLYMYOSITIS"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04034056",
          "briefTitle": "Untreated FolliculaR Lymphoma Treated With OBinituzumAb in a Non-interventional Study (URBAN)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-09-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-04-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Follicular Lymphoma"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 299,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02356159",
          "briefTitle": "Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-09-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-03-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Myelodysplastic Syndromes", "Hodgkin's Lymphoma", "Non-Hodgkin's Lymphoma", "Acute Leukemia", "Multiple Myeloma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 34,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01446211",
          "briefTitle": "Clinical Study Comparing the New Immunosuppressive Drug Gusperimus With the Conventional Treatment in Wegener's Granulomatosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-11"
          },
          "completionDateStruct": {
            "date": "2015-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Wegeners Granulomatosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 4,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06567054",
          "briefTitle": "Clinical Study to Predict the Risk of Bone Fractures With the POROUS Ultrasound Device"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-03-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Healthy", "Osteopenia", "Osteoporosis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1600,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "56 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00642018",
          "briefTitle": "A Study of an Experimental Chemotherapy Combination to Treat Hormone Refractory Prostate Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-03"
          },
          "completionDateStruct": {
            "date": "2012-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Prostate Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 154,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00772668",
          "briefTitle": "Rituximab, Cyclophosphamide, Bortezomib, and Prednisone in Patients With Stage III/IV FL or MZL"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-09-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2011-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Lymphoma", "Follicular Lymphoma", "Marginal Zone Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 3,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "17 Years",
          "maximumAge": "120 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00642460",
          "briefTitle": "A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Systemic Juvenile Idiopathic Arthritis (JIA)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-05"
          },
          "completionDateStruct": {
            "date": "2014-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Juvenile Idiopathic Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 112,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02953678",
          "briefTitle": "A Study of Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease (REACH-1)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-12-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-08-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Graft-versus-host Disease (GVHD)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 71,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07108387",
          "briefTitle": "Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell Arteritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12-15",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-02-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Giant Cell Arteritis (GCA)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 78,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06060587",
          "briefTitle": "Randomized Phase II Study of ADT + Abiraterone vs ADT + Docetaxel + Abiraterone"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-10-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-12-22",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Prostate Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01858441",
          "briefTitle": "Pharmacogenetic Study in Castration-resistant Prostate Cancer Patients Treated With Abiraterone Acetate"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-04"
          },
          "completionDateStruct": {
            "date": "2020-12-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pharmacogenetic Study"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 148,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years",
          "maximumAge": "90 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03453021",
          "briefTitle": "Effect of Mepolizumab on Decrease of Systemic Corticosteroids in Patients With Severe Eosinophilic Asthma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-01-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-10-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma; Eosinophilic"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 27,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01394276",
          "briefTitle": "An Observational Study on RoActemra/Actemra (Tocilizumab) in Clinical Practice in Patients With Rheumatoid Arthritis (TRUST)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-05"
          },
          "completionDateStruct": {
            "date": "2013-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 322,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03279250",
          "briefTitle": "Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-10-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-05-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Prostate Adenocarcinoma", "Stage IIB Prostate Cancer AJCC v8", "Stage IIC Prostate Cancer AJCC v8", "Stage IIIA Prostate Cancer AJCC v8", "Stage IIIC Prostate Cancer AJCC v8"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 86,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06827587",
          "briefTitle": "Efficacy and Safety of Efgartigimod Sequential Therapy with Telitacicept in Generalized Myasthenia Gravis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-02",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Myasthenia Gravis", "Autoimmune Diseases", "Neuromuscular Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03943901",
          "briefTitle": "Split-Dose R-CHOP for Older Adults With DLBCL"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-02-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-02",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Diffuse Large B Cell Lymphoma", "DLBCL", "Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 26,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06635720",
          "briefTitle": "REduced-dose Steroid PrOtocol for Childhood Nephrotic SyndromE (RESPONSE)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-11-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-11-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Nephrotic Syndrome in Children", "Nephrotic Syndrome, Minimal Change", "Nephrotic Syndrome", "Nephrotic Syndrome，Idiopathic"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Year",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02997605",
          "briefTitle": "Comparison of Two Strategies of Glucocorticoid Withdrawal in Rheumatoid Arthritis Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-01-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-01-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "RheumatoId Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 102,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03043105",
          "briefTitle": "TCP Regimen in Newly Diagnosed MCD:a Prospective, Single-center, Single-arm, Phase-II Pilot Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-01-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-01-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Multicentric Castleman Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04729114",
          "briefTitle": "A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-06-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-05-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Prostate Cancer", "Metastatic Castration Resistant Prostate Cancer", "Metastatic Castration-sensitive Prostate Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 174,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01957436",
          "briefTitle": "A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-11-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2032-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Metastatic Prostate Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1173,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02328963",
          "briefTitle": "Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-05-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-10-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Transplantation Infection", "Cytomegalovirus Infection"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 186,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05428826",
          "briefTitle": "Early Discontinuation of Steroid Treatment in Negative FDG-PET/CT Patients With Idiopathic Retroperitoneal Fibrosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-11-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-11-25",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Idiopathic Retroperitoneal Fibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 41,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02337517",
          "briefTitle": "Vismodegib in Treating Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-09-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-06-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Graft Versus Host Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 6,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04263584",
          "briefTitle": "Copanlisib in Combination With Rituximab and CHOP Chemotherapy in Patients With Previously Untreated DLBCL"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-06-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Diffuse Large B Cell Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 62,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07242092",
          "briefTitle": "Influence of Methotrexate Discontinuation on Immunogenicity After PCV-20 Vaccine in Patients ARDs"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-01-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-12-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Autoimmune Rheumatic Diseases"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 192,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06598332",
          "briefTitle": "5-Azacytidine With Steroids for Gastrointestinal GVHD (5-AZA FOR GVHD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-08",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-05-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Graft-Versus-Host Disease(GVHD)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02145598",
          "briefTitle": "Treatment Optimization in Patients With Untreated Multiple Myeloma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-12-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 85,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00617604",
          "briefTitle": "A Study to Assess the Efficacy and Safety of Alefacept in Kidney Transplant Recipients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-12"
          },
          "completionDateStruct": {
            "date": "2009-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "De Novo Kidney Transplantation"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 218,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "64 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04411654",
          "briefTitle": "Phase 1/2 Clinical Trial of PR001 in Infants With Type 2 Gaucher Disease (PROVIDE)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-06-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Gaucher Disease, Type 2"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 7,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "0 Months",
          "maximumAge": "24 Months"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06510530",
          "briefTitle": "Astragalus for Symptomatic Alleviation in High-grade Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-08",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2032-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "High-grade Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02531633",
          "briefTitle": "Efficacy and Safety Study of Sirukumab in Patients With Giant Cell Arteritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-10-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-03-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Giant Cell Arteritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 161,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04702256",
          "briefTitle": "Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMF"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2031-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Lupus Nephritis", "Systemic Lupus Erythematosus (SLE)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 196,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "14 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01933724",
          "briefTitle": "The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-02-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Granulomatosis With Polyangiitis", "Wegener Granulomatosis", "Vasculitis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01631058",
          "briefTitle": "Renal Transplantation in the Elderly - nEverOld Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-07"
          },
          "completionDateStruct": {
            "date": "2019-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Renal Failure (CRF)", "Graft Failure", "Transplant; Failure, Kidney", "Renal Transplant Rejection"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 90,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05090384",
          "briefTitle": "Pediatric GVHD Low Risk Steroid Taper Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-10-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Graft vs Host Disease", "Allogeneic Bone Marrow Transplantation", "Adverse Effects"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00048789",
          "briefTitle": "Extracorporeal Photopheresis to Treat Chronic Graft-Versus-Host Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2002-11-04"
          },
          "completionDateStruct": {
            "date": "2009-01-29"
          }
        },
        "conditionsModule": {
          "conditions": "Graft vs Host Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "4 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02985957",
          "briefTitle": "A Study of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer (CheckMate 650)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-03-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-01-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Prostate Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 351,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02110706",
          "briefTitle": "BeatMG: Phase II Trial of Rituximab In Myasthenia Gravis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-05"
          },
          "completionDateStruct": {
            "date": "2018-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Myasthenia Gravis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 52,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "21 Years",
          "maximumAge": "90 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06818019",
          "briefTitle": "Withdrawal of Dupilumab in Severe Asthma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-04-02",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Severe Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 205,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05371054",
          "briefTitle": "Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-04-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-01-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Lymphoma", "Non-Hodgkin Lymphoma", "NHL", "Hematologic Malignancies", "Lymphoid Malignancies"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 8,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04903054",
          "briefTitle": "Selective CD28 Blockade in Renal Transplant Recipients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-01-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-09-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Kidney Transplantation", "Renal Transplant Recipients"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04486391",
          "briefTitle": "Tislelizumab Monotherapy Versus Salvage Chemotherapy for Relapsed/Refractory Classical Hodgkin Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-09-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-10-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Classical Hodgkin Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 3,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06763783",
          "briefTitle": "Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-12-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2034-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Systemic Vasculitis", "Spondylarthropathies", "Psoriatic Arthritis", "Scleroderma", "Polymyalgia Rheumatica (PMR)", "Juvenile Chronic Arthritis", "Polyarthritis", "SLE", "Giant Cell Arteritis (GCA)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 240,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05006664",
          "briefTitle": "Brentuximab Vedotin in Combination With CHEP in Patient With PTCL"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-10",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2024-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Lymphoma, T-Cell, Peripheral"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 33,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02043678",
          "briefTitle": "Radium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has Spread to the Bone, Has Not Been Treated With Chemotherapy and is Causing no or Only Mild Symptoms"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-03-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-02-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Prostatic Neoplasms"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 806,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01092182",
          "briefTitle": "Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-03-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-02-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Burkitt Lymphoma", "Diffuse Large B-cell Lymphoma, c-MYC Positive", "Plasmablastic Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 194,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00423098",
          "briefTitle": "Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Combination With Two Corticosteroid Regimens for the Treatment of Lupus Nephritis Flare"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-02"
          },
          "completionDateStruct": {
            "date": "2009-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lupus Nephritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 81,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05623592",
          "briefTitle": "Methotrexate as Remission Maintenance Therapy After Remission-Induction With Tocilizumab and Glucocorticoids in Giant Cell Arteritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-11-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Giant Cell Arteritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 52,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05975450",
          "briefTitle": "Subcutaneous Abatacept in Renal Transplant Recipients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-08-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-02-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Kidney Transplant Recipient"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 14,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00623766",
          "briefTitle": "Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain Metastases"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-07"
          },
          "completionDateStruct": {
            "date": "2012-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Melanoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 99,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03649841",
          "briefTitle": "Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-06-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-02-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Castration-Sensitive Prostate Carcinoma", "Metastatic Malignant Neoplasm in the Bone", "Metastatic Prostate Carcinoma", "Prostate Adenocarcinoma", "Prostate Small Cell Neuroendocrine Carcinoma", "Stage IV Prostate Cancer AJCC v8", "Stage IVA Prostate Cancer AJCC v8", "Stage IVB Prostate Cancer AJCC v8"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01992653",
          "briefTitle": "A Study of Polatuzumab Vedotin in Combination With Rituximab or Obinutuzumab, Cyclophosphamide, Doxorubicin, and Prednisone in Participants With B-Cell Non-Hodgkin's Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-11-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-12-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lymphoma, Non Hodgkin"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 85,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00001337",
          "briefTitle": "Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "1993-05-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-05-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Diffuse Large B-Cell Lymphoma (DLBCL)", "Primary Mediastinal Large B-cell Lymphoma", "Burkitt Lymphoma", "Anaplastic Large-Cell Lymphoma", "Gray Zone Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 348,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00101101",
          "briefTitle": "Universal Granulocyte Macrophage-colony Stimulating Factor (GM-CSF)-Producing and GM.CD40L for Autologous Tumor Vaccine in Mantle Cell Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-06-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 43,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03939637",
          "briefTitle": "Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-05-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-02-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Immune Thrombocytopenia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 122,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Year",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05349006",
          "briefTitle": "Azathioprine in MOGAD"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-12-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-12-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Central Nervous System Inflammation", "MOG-IgG Associated Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 126,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04047628",
          "briefTitle": "Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-12-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Relapsing Multiple Sclerosis", "Relapsing Remitting Multiple Sclerosis", "Secondary Progressive Multiple Sclerosis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 156,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02714634",
          "briefTitle": "Clinical Trial Evaluating Methotrexate or Leflunomide + Targeted Therapy Versus Methotrexate or Leflunomide + Sulfasalazine + Hydroxychloroquine in Patients With Rheumatoid Arthritis and Insufficient Response to Methotrexate or Leflunomide"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-03-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Rheumatoid Arthritis", "Insufficient Response to Methotrexate or Leflunomide"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 286,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05979441",
          "briefTitle": "A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-09-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Myositis", "Active Idiopathic Inflammatory Myopathy", "Dermatomyositis", "Polymyositis", "Immune-Mediated Necrotizing Myopathy", "Antisynthetase Syndrome"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 240,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01632241",
          "briefTitle": "Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-02-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-01-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Systemic Lupus Erythematosus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 503,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01055496",
          "briefTitle": "Study Evaluating Chemotherapy in Combination With Inotuzumab Ozogamicin In Subjects With Non-Hodgkin's Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2014-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lymphoma, B-Cell"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 103,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01663714",
          "briefTitle": "Open Label Multicenter Study of CVP Followed by Iodine-131 Anti-B1 Antibody for Subjects With Untreated Low-Grade Non Hodgkin's Lymphoma."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2000-02"
          },
          "completionDateStruct": {
            "date": "2012-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lymphoma, Non-Hodgkin"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00685399",
          "briefTitle": "Safety and Efficacy of AIN457 in Noninfectious Uveitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-06"
          },
          "completionDateStruct": {
            "date": "2013-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Non-infectious Uveitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 76,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00410410",
          "briefTitle": "A Study of Abatacept in Patients With Active Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-12"
          },
          "completionDateStruct": {
            "date": "2009-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 591,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00744497",
          "briefTitle": "Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-10"
          },
          "completionDateStruct": {
            "date": "2015-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Prostatic Neoplasms"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1930,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02594735",
          "briefTitle": "Abatacept in Juvenile Dermatomyositis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-11"
          },
          "completionDateStruct": {
            "date": "2021-10-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Dermatomyositis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "7 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01213394",
          "briefTitle": "Mycophenolate Mofetil for Reducing Cardiovascular Risk in Renal Transplant Recipients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-10"
          },
          "completionDateStruct": {
            "date": "2011-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Kidney Transplantation", "Cardiovascular Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "30 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00278408",
          "briefTitle": "Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-01-02"
          },
          "completionDateStruct": {
            "date": "2018-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 700,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03967925",
          "briefTitle": "Rituximab and Belimumab Combination Therapy in PR3 Vasculitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-02-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["ANCA Associated Vasculitis", "Granulomatosis With Polyangiitis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 31,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00634647",
          "briefTitle": "Satraplatin and Prednisone to Treat Prostate Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-02-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2012-05-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Prostate Cancer", "Genetic Polymorphism"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 24,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03981081",
          "briefTitle": "Prednisone Reduction in ICU Patients With COPD Exacerbation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-04-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-04-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Copd Exacerbation Acute", "Mechanical Ventilation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 192,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03345407",
          "briefTitle": "Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-11-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-01-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pulmonary Disease, Chronic Obstructive"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 943,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00051311",
          "briefTitle": "Modified Stem Cell Transplant Procedure to Treat Patients With Blood and Immune System Cancers"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2003-01-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2014-09-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hematologic Neoplasms"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 62,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03444805",
          "briefTitle": "EBMT ADWP Prospective Non-interventional Study: Post-AHSCT Management in SSC Patients (NISSC-2)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-07-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-03-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Autoimmune Diseases"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03003520",
          "briefTitle": "A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-02-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-04-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lymphoma, Large B-Cell, Diffuse"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 46,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02115997",
          "briefTitle": "A Study Evaluating the Safety and Efficacy of Rituximab in Combination With Glucocorticoids in Participants With Wegener's Granulomatosis or Microscopic Polyangitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-07-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-06-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Wegener's Granulomatosis or Microscopic Polyangiitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01950819",
          "briefTitle": "Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-12-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-01-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["End Stage Renal Disease (ESRD)", "Chronic Kidney Disease (CKD)", "Hemodialysis", "Renal Replacement Therapy", "Renal Transplantation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2037,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01946880",
          "briefTitle": "Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-11-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-07-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Systemic Lupus Erythematosus", "SLE"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 102,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01614977",
          "briefTitle": "Comparison of Antibiotic Therapy Alone or Combined With Corticosteroids for the Treatment of Nontuberculous Mycobacterial Cervicofacial Lymphadenitis in Children: A Randomized Double-Blind Placebo-Controlled Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-10"
          },
          "completionDateStruct": {
            "date": "2014-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Nontuberculous Mycobacterial Lymphadenitis."
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "3 Months",
          "maximumAge": "20 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01714817",
          "briefTitle": "Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-01-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-05-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lupus Nephritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 695,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00675584",
          "briefTitle": "CARE Network Maintenance Versus Intermittent Inhaled Steroids in Wheezing Toddlers (MIST)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-08"
          },
          "completionDateStruct": {
            "date": "2010-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 278,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Months",
          "maximumAge": "53 Months"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00006436",
          "briefTitle": "EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2001-01-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-01-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Lymphoma, AIDS-related", "Lymphoma, Large B-Cell, Diffuse"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 68,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01364389",
          "briefTitle": "A 3-arm Proof of Concept Study of AIN457, ACZ885 or Corticosteroids in Patients With Polymyalgia Rheumatica"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-02-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2013-01-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Polymyalgia Rheumatica", "Inflammatory Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 16,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years",
          "maximumAge": "85 Years"
        }
      }
    ],
    "protocolSection.1": [
      {
        "identificationModule": {
          "nctId": "NCT04424862",
          "briefTitle": "Multitarget Therapy for Idiopathic Membranous Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-06-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-02-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Efficacy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 82,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07309614",
          "briefTitle": "A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2030-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma Control"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 150,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "79 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06522100",
          "briefTitle": "Corticoid Therapy in Acute Myocarditis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-02-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-08-16",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Myocarditis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 420,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04294641",
          "briefTitle": "Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-05-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-06-28",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic GVHD"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02132195",
          "briefTitle": "Adrenocorticotropic Hormone (ACTH) for Frequently Relapsing and Steroid Dependent Nephrotic Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Nephrotic Syndrome"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 31,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "20 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02268045",
          "briefTitle": "Study of RTXM83 Plus CHOP Chemotherapy Versus a Rituximab Plus CHOP Therapy in Patients With Non Hodgkin's Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-05"
          },
          "completionDateStruct": {
            "date": "2017-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Diffuse Large B-cell Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 272,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02854631",
          "briefTitle": "Selonsertib in Combination With Prednisolone Versus Prednisolone Alone in Participants With Severe Alcoholic Hepatitis (AH)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-09-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-05-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Alcoholic Hepatitis (AH)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 104,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00211185",
          "briefTitle": "A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-03-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2009-12-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lymphoma, T-Cell, Peripheral"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 49,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02533180",
          "briefTitle": "Evaluation of Donor Specific Immune Senescence and Exhaustion as Biomarkers of Tolerance Post Liver Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-12-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-07-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Liver Transplant", "Liver Transplantation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03269669",
          "briefTitle": "Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-01-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Grade 1 Follicular Lymphoma", "Grade 2 Follicular Lymphoma", "Grade 3a Follicular Lymphoma", "Recurrent Follicular Lymphoma", "Refractory Follicular Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 95,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02994927",
          "briefTitle": "A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-03-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-11-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "ANCA-Associated Vasculitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 331,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07279688",
          "briefTitle": "Justification And Evaluation of Baricitinib Plus Corticosteroids Versus corticosteroiDs Alone in pOlymyalgia RhEumatica"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12-12",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-06-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Polymyalgia Rheumatica (PMR)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 140,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05329090",
          "briefTitle": "Evaluation of Glucocorticoids Plus Rituximab in Patients with Newly-Diagnosed or Relapsing IgA Vasculitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-03-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-01-16",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "IgA Vasculitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 75,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01335685",
          "briefTitle": "Study of Oral Ixazomib in Combination With Melphalan and Prednisone in Participants With Newly Diagnosed Multiple Myeloma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-06-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-12-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 61,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00005780",
          "briefTitle": "Chemotherapy Plus Vaccination to Treat Mantle Cell Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2000-06-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-06-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Mantle Cell Lymphoma", "Lymphoma, Mantle Cell"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 26,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07112209",
          "briefTitle": "Clinical Study of Rezvilutamide Combined With Docetaxel Chemotherapy in the Treatment of Abiraterone-Resistant Prostate Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-11-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-11-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Pathological and Imaging Examinations Confirmed Metastatic Prostate Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04736108",
          "briefTitle": "Neoadjuvant Therapy of Abiraterone Plus ADT for Intraductal Carcinoma of the Prostate"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-05",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2024-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Prostate Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05772871",
          "briefTitle": "The Efficacy and Safety of Prednisone Combined With Huaiqihuang Granule for Primary Nephrotic Syndrome in Children"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-04-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-10-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Nephrotic Syndrome in Children"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 402,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Months",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00466440",
          "briefTitle": "A Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-06"
          },
          "completionDateStruct": {
            "date": "2010-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Prostate Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 108,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02911935",
          "briefTitle": "Azithromycin to Prevent Wheezing Following Severe RSV Bronchiolitis-II"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Respiratory Syncytial Virus, Bronchiolitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Month",
          "maximumAge": "18 Months"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07215754",
          "briefTitle": "Real World Evidence of Anifrolumab in Systemic Lupus Erythematosus: Investigator Initiated, Observational, Multicenter Study Evaluating Effectiveness and Safety of Anifrolumab in Active SLE Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-05-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2031-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Systemic Lupus Erythematosus"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 300,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06453694",
          "briefTitle": "Efgartigimod for the Treatment of Acute Optic Neuritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-08-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Optic Neuritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02070978",
          "briefTitle": "Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-07-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-02-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lupus Erythematosus, Systemic"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 253,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00104299",
          "briefTitle": "Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-01"
          },
          "completionDateStruct": {
            "date": "2010-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Vasculitis", "Wegener's Granulomatosis", "Microscopic Polyangiitis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 197,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "15 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06983821",
          "briefTitle": "Safe Effective Therapy With Low-Dose Glucocorticoid in ANCA-Associated Vasculitis (SAFE-LOW)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-08",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-02",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Granulomatosis With Polyangiitis", "Microscopic Polyangiitis (MPA)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06516978",
          "briefTitle": "A Study Comparing the Efficacy and Safety of Pola-RCHP-X Versus RCHOP-X and Pola-RCHP in Previously Untreated Patients With DLBCL"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-10-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-04-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Diffuse Large B Cell Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 528,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05605899",
          "briefTitle": "Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-02-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2031-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "High-risk Large B-cell Lymphoma (LBCL)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 300,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04660799",
          "briefTitle": "A Study on Pharmacokinetics (PK), Efficacy and Safety of Subcutaneous (SC) Versus Intravenous (IV) Rituximab, in Combination With CHOP (Cyclophosphamide, Doxorubicin, Vincristine, Prednisone) in Previously Untreated Participants With CD20 Positive Diffuse Large B-Cell Lymphoma (DLBCL)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-02-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-10-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lymphoma, Large B-Cell, Diffuse"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00283712",
          "briefTitle": "Use of Infliximab for the Treatment of Pemphigus Vulgaris"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-03"
          },
          "completionDateStruct": {
            "date": "2011-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pemphigus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03164473",
          "briefTitle": "Maintenance of Remission With Rituximab Versus Azathioprine for Newly-diagnosed or Relapsing Eosinophilic Granulomatosis With Polyangiitis."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-03-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-09-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Eosinophilic Granulomatosis With Polyangiitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 98,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00327340",
          "briefTitle": "Evaluation of Safety and Feasibility of OGX-011 in Combination With 2nd-line Chemotherapy in Patients With HRPC"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-07"
          },
          "completionDateStruct": {
            "date": "2010-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Prostate Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 70,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04933617",
          "briefTitle": "Copanlisib With Dose-Adjusted EPOCH-R in Relapsed and Refractory Burkitt Lymphoma and Other High-Grade B-cell Lymphomas"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-03-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-11-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Burkitt Lymphoma", "High-grade B-cell Lymphoma", "T-cell/Histocyte-rich Large B-cell Lymphoma", "Diffuse Large B-Cell Lymphoma (DLBCL)", "Germinal Center B-cell Type (GCB)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 8,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04599634",
          "briefTitle": "Venetoclax With Obinutuzumab and Magrolimab (VENOM) in Relapsed and Refractory Indolent B-cell Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-06-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Follicular Lymphoma", "Marginal Zone Lymphoma", "Mantle Cell Lymphoma", "Chronic Lymphocytic Lymphoma", "B-Cell Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 11,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07132164",
          "briefTitle": "Justification of the Initial Diagnosis and Evaluation of the Overall Evolution of a Cohort of Recent Polymyalgia Rheumatica (JADORE)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-10-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2034-10-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Polymyalgia Rheumatica", "Inflammatory Rheumatism"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 400,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03239470",
          "briefTitle": "Polyclonal Regulatory T Cells (PolyTregs) for Pemphigus"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-10-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-01-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Pemphigus Foliaceus", "Pemphigus Vulgaris"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 5,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01889069",
          "briefTitle": "A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Rituximab (MabThera/Rituxan) in Participants With Diffuse Large B Cell Lymphoma (DLBCL) or Follicular Lymphoma (FL)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-07-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-05-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 159,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05347771",
          "briefTitle": "Prevention of Asthma Exacerbations Using Dupilumab in Urban Children and Adolescents"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-05-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 240,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02959944",
          "briefTitle": "Ibrutinib in Combination With Corticosteroids vs Placebo in Combination With Corticosteroids in Participants With New Onset Chronic Graft Versus Host Disease (cGVHD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-05-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-07-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Graft Versus Host Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 193,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07268521",
          "briefTitle": "A Multicenter Phase 2 Single-arm Proof-of-concept Trial Assessing the Efficacy and Safety of Obinutuzumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Refractory or Intolerant to Rituximab"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-09-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Cryoglobulinemic Vasculitis (CV)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00683475",
          "briefTitle": "A Study of IMC-A12 or Ramucirumab Plus Mitoxantrone and Prednisone in Prostate Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-08"
          },
          "completionDateStruct": {
            "date": "2011-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Prostate Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 138,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02613910",
          "briefTitle": "Long-Term Extension Study of Ofatumumab in Subjects With Pemphigus Vulgaris"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-12-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-03-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pemphigus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02226146",
          "briefTitle": "Evaluation of Safety, Efficacy and Pharmacodynamic Effect of Bertilimumab in Patients With Bullous Pemphigoid"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-02-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-04-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pemphigoid, Bullous"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 11,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03970577",
          "briefTitle": "RItuximab From the FIRst Episode of Idiopathic Nephrotic Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-07-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-11-29",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Minimal Change Nephrotic Syndrome (MCNS)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 148,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00278421",
          "briefTitle": "Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-11"
          },
          "completionDateStruct": {
            "date": "2018-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 592,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06337695",
          "briefTitle": "VERIFY: Vedolizumab for the Prevention of Immune Checkpoint Inhibitor Related Diarrhea or Colitis in Patients With Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-07-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Cancer", "Cancer Metastatic"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 298,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06126380",
          "briefTitle": "Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-10-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Kidney Transplant Rejection"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 132,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00430677",
          "briefTitle": "Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-06"
          },
          "completionDateStruct": {
            "date": "2011-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Systemic Lupus Erythematosus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 423,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03562065",
          "briefTitle": "Treatment of Refractory Systemic Lupus Erythematosus by Allogeneic Mesenchymal Stem Cells Derived From the Umbilical Cord"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-09-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-06-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Lupus Erythematosus", "Stem Cell Transplant"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03049449",
          "briefTitle": "T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-03-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-01-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Lymphoma, Large-Cell, Anaplastic", "Enteropathy-Associated T-Cell Lymphoma", "Lymphoma, Large B-Cell, Diffuse", "Lymphoma, Extranodal NK-T-Cell", "Lymphoma, T-Cell, Peripheral"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 26,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "73 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06780462",
          "briefTitle": "Randomized Controlled Multicenter Study Comparing Steroid Therapy Plus Anticoagulants to Steroid Therapy Alone in Deep Venous Thrombosis of Behçet's Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-01-15",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-01-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Behcet Syndrome"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 134,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03843125",
          "briefTitle": "A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-09-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-04-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Systemic Lupus Erythematosus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1147,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04408625",
          "briefTitle": "Phase 1/2 Clinical Trial of LY3884963 in Patients With Frontotemporal Dementia With Progranulin Mutations (FTD-GRN)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-11-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2031-04-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Frontotemporal Dementia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 35,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "30 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07053462",
          "briefTitle": "CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-12-28",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["End-Stage Renal Disease", "End Stage Renal Disease on Dialysis", "End Stage Renal Disease With Renal Transplant", "Kidney Transplant Rejection", "Kidney Tumor", "Kidney Failure", "Kidney Ischemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 90,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02159690",
          "briefTitle": "A Phase II Neoadjuvant Study of Enzalutamide, Abiraterone Acetate, Dutasteride and Degarelix in Men With Localized Prostate Cancer Pre-prostatectomy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-09"
          },
          "completionDateStruct": {
            "date": "2015-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Prostate Cancer", "Localized Prostate Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03017014",
          "briefTitle": "A Study to Assess Safety and Effectiveness of Adalimumab for Treating Children and Adolescents With Crohn's Disease in Real Life Conditions"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-09-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-10-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 62,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05327894",
          "briefTitle": "Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-12-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Lymphoblastic Leukemia", "Mixed Phenotype Acute Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 160,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Day",
          "maximumAge": "1 Year"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00406653",
          "briefTitle": "A Study of Abatacept in Patients With Active Crohn's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-12"
          },
          "completionDateStruct": {
            "date": "2009-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Crohn's Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 451,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04058028",
          "briefTitle": "Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-02-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-07-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Systemic Lupus Erythematosus (SLE)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 244,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01106352",
          "briefTitle": "A Study of Alpharadin With Docetaxel in Patients With Bone Metastasis From Castration-Resistant Prostate Cancer (CRPC)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-07"
          },
          "completionDateStruct": {
            "date": "2015-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Bone Metastases", "Castration-Resistant Prostate Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 70,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00288626",
          "briefTitle": "High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-07"
          },
          "completionDateStruct": {
            "date": "2015-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Relapsing-Remitting Multiple Sclerosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01580865",
          "briefTitle": "Comparison Between Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) for Induction of Remission in Lupus Nephritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-05"
          },
          "completionDateStruct": {
            "date": "2017-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lupus Nephritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 84,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00443430",
          "briefTitle": "Trial of Early Aggressive Drug Therapy in Juvenile Idiopathic Arthritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-05"
          },
          "completionDateStruct": {
            "date": "2010-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Juvenile Chronic Polyarthritis", "Juvenile Idiopathic Arthritis", "Juvenile Rheumatoid Arthritis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 85,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05879419",
          "briefTitle": "Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-05-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2032-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Rheumatoid Arthritis", "Spondylitis, Ankylosing", "Spondyloarthritis", "Systemic Lupus Erythematosus", "Sjogren's Syndrome", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathies", "Vasculitis, Systemic", "Juvenile Idiopathic Arthritis", "Dermatomyositis, Juvenile", "Behçet Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2005,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00693381",
          "briefTitle": "Mycophenolate Mofetil (MMF) Discontinuation From a Tacrolimus/MMF/Steroid Triple Regimen After Kidney Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2003-02"
          },
          "completionDateStruct": {
            "date": "2004-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Kidney Transplantation"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 152,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03290456",
          "briefTitle": "Evaluate the Remission MAINtenance Using Extended Administration of Prednisone in Systemic Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-08-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-10-20",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Granulomatosis With Polyangitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 146,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00290667",
          "briefTitle": "Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-02"
          },
          "completionDateStruct": {
            "date": "2015-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 586,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "61 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02647255",
          "briefTitle": "Trial of Plasma Exchange for Severe Crescentic IgA Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Glomerulonephritis, IGA", "Kidney Diseases", "Acute Renal Insufficiency", "Rapidly Progressive Glomerulonephritis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "14 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00989235",
          "briefTitle": "Substudy - Low Dose of Abatacept in Subjects With Rheumatoid Arthritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-04"
          },
          "completionDateStruct": {
            "date": "2009-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 108,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02626455",
          "briefTitle": "Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-01-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-11-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lymphoma, Non-Hodgkin"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 551,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00931918",
          "briefTitle": "Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-10"
          },
          "completionDateStruct": {
            "date": "2015-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 206,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05933213",
          "briefTitle": "Comparing Mescaline Sodium Enteric-coated Tablets vs Morte-mescaline in the Treatment of Adult Lupus Nephritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-07-06",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2025-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Lupus Nephritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 205,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02205762",
          "briefTitle": "LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-11-02"
          },
          "completionDateStruct": {
            "date": "2026-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Langerhans Cell Histiocytosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1400,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07266090",
          "briefTitle": "A Study to Evaluate the Safety,Tolerability,Pharmacokinetics and Pharmacodynamics of Cenerimod in Adult Chinese Participants With Moderate-to-severe Systemic Lupus Erythematosus (SLE)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-11-28",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-10-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "SLE - Systemic Lupus Erythematosus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07245732",
          "briefTitle": "Oral Versus Intramuscular Steroid Use to Control Rheumatoid Arthritis Flares"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-04",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis (RA)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 220,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04738812",
          "briefTitle": "Determination of Adequate Tuberculosis Regimen in Patients Hospitalized With HIV-associated Severe Immune Suppression"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-04-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-11-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Tuberculosis", "HIV-1-infection", "Immuno-Deficiency"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1330,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "15 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04362501",
          "briefTitle": "Efficacy of Dupilumab for Patients With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-10-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-09-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Sinusitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 33,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06143891",
          "briefTitle": "A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-01-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-09-29",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Graft Versus Host Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 260,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00119678",
          "briefTitle": "Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With Prednisone"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-09"
          },
          "completionDateStruct": {
            "date": "2008-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Systemic Lupus Erythematosus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 183,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04918147",
          "briefTitle": "Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-10-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-01-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["IgG4 Related Disease", "IgG4-RD"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 8,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02383589",
          "briefTitle": "A Study to Evaluate the Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil (MMF) in Participants With Pemphigus Vulgaris (PV)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-05-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-10-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pemphigus Vulgaris"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 135,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05352919",
          "briefTitle": "An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-06-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-03-29",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Systemic Lupus Erythematosus (SLE)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 864,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02663193",
          "briefTitle": "Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-12"
          },
          "completionDateStruct": {
            "date": "2017-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Prostate Cancer"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 108,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02137239",
          "briefTitle": "Regimen Optimization Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-12-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-05-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Kidney Transplantation"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 58,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00715208",
          "briefTitle": "Phase 2 Study of VELCADE (Bortezomib) in Patients With Relapsed Follicular Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-09"
          },
          "completionDateStruct": {
            "date": "2011-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Relapsed Follicular Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 55,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04623541",
          "briefTitle": "Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-11-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Relapsed/Refractory Chronic Lymphocytic Leukemia", "Small Lymphocytic Lymphoma", "Richter's Syndrome", "Treatment-naïve High Risk Chronic Lymphocytic Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 424,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00294658",
          "briefTitle": "Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-06"
          },
          "completionDateStruct": {
            "date": "2015-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Myasthenia Gravis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 126,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03762265",
          "briefTitle": "A Study of PRN1008 in Patients With Pemphigus"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-01-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-12-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pemphigus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 131,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02287610",
          "briefTitle": "A Non-Interventional Study of RAYOS in Adult Patients With Rheumatoid Arthritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-11"
          },
          "completionDateStruct": {
            "date": "2015-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 75,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03295565",
          "briefTitle": "Optimal Sequencing of Treatment Options for Poor Risk mCRPC Previously Treated With Docetaxel"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-05-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-03-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Prostate Cancer Metastatic", "Metastasis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01641107",
          "briefTitle": "Phase II Front-line Ponatinib in Adult Philadelphia+/BCR-ABL+ Acute Lymphoblastic Leukemia."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-12-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-09-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Philadelphia Positive", "BCR-ABL Positive", "Acute Lymphoblastic Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 44,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05848011",
          "briefTitle": "A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-09-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Androgen-Independent Prostatic Cancer", "Androgen-Independent Prostatic Neoplasms", "Prostate Cancer Recurrent", "Androgen-Insensitive Prostatic Cance", "Androgen-Resistant Prostatic Cancer", "Hormone Refractory Prostatic Cancer", "Immunotherapy", "Immune Checkpoint Inhibitor", "Inhibitory Checkpoint Molecule"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 154,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05405439",
          "briefTitle": "To Evaluate the Efficacy of TQB3823 Combined With Abiraterone and Prednisone in Metastatic Castration-resistant Prostate Cancer Patientsprednisone Acetate Tablets in Patients With Metastatic Castration-resistant Prostate Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-08-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-07-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Metastatic Castration-resistant Prostate Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 39,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years",
          "maximumAge": "85 Years"
        }
      }
    ]
  }
}
